End stage and chronic kidney disease: associations with renal cancer

Paul Russo, Paul Russo

Abstract

There is a well known association between end stage renal disease and the development of kidney cancer in the native kidney of patients requiring renal replacement therapy. There is now emerging evidence that lesser degrees of renal insufficiency (chronic kidney disease, CKD) are also associated with an increased likelihood of cancer in general and kidney cancer in particular. Nephropathological changes are commonly observed in the non-tumor bearing portions of kidney resected at the time of partial and radical nephrectomy (RN). In addition, patients with renal cancer are more likely to have CKD at the time of diagnosis and treatment than the general population. The exact mechanism by which renal insufficiency transforms normal kidney cells into tumor cells is not known. Possible mechanisms include uremic immune inhibition or increased exposure to circulating toxins not adequately cleared by the kidneys. Surgeons managing kidney tumors must have an increased awareness of their patient's renal functional status as they plan their resection. Kidney sparing approaches, including partial nephrectomy (PN) or active surveillance in older and morbidly ill patients, can prevent CKD or delay the further decline in renal function which is well documented with RN. Despite emerging evidence that PN provides equivalent local tumor control to RN while at the same time preventing CKD, this operation remains under utilized in the United States and abroad. Increased awareness of the bi directional relationship between kidney function and kidney cancer is essential in the contemporary management of kidney cancer.

Keywords: chronic kidney disease; kidney cancer; partial nephrectomy; radical nephrectomy; renal insufficiency.

References

    1. Algaba F., Akaza H., López-Beltrán A., Martignoni G., Moch H., Montironi R., Reuter V. (2011). Current pathology keys of renal cell carcinoma. Eur. Urol. 60, 634–64310.1016/j.eururo.2011.06.047
    1. Bijol V., Mendez G. P., Hurwitz S., Rennke H. G., Nosé V. (2006). Evaluation of the nonneoplastic pathology in tumor nephrectomy specimens: predicting the risk of progressive renal failure. Am. J. Surg. Pathol. 30, 575.10.1097/01.pas.0000194296.74097.87
    1. Birkelan S. A., Lokkegaard H., Storm H. H. (2000). Cancer risk in patients on dialysis and after renal transplantation. Lancet 355, 1886–188710.1016/S0140-6736(00)02298-4
    1. Bonsib S. M., Pei Y. (2010). The non-neoplastic kidney in tumor nephrectomy specimens: what can it show and what is important? Adv. Anat. Pathol. 4, 235–25010.1097/PAP.0b013e3181e3c02d
    1. Buell J. F., Gross T. G., Woodle E. S. (2005). Malignancy after transplantation. Transplantation 80, S254–S26410.1097/
    1. Campbell S. C., Novick A. C., Belldegrun A., Blute M. L., Chow G. K., Derweesh I. H., Faraday M. M., Kaouk J. H., Leveille R. J., Matin S. F., Russo P., Uzzo R. G. (2009). Guideline for management of the clinical T1 renal mass. J. Urol. 182, 1271–127910.1016/j.juro.2009.08.194
    1. Cengiz K. (2002). Increased incidence of neoplasia in chronic renal failure (20 year experience). Int. Urol. Nephrol. 33, 121–12610.1023/A:1014494012062
    1. Chobanian A. V., Bakris G. L., Black H. R., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., the National High Blood Pressure Education Program Coordinating Committee (2003). The Seventh Report of the Joint National Committee on TN prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289, 2560–257210.1001/jama.289.19.2560
    1. Coresh J., Selvin E., Stevens L. A., Manzi J., Kusek J. W., Eggers P., Van Lente F., Levey A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA 298, 2038–204710.1001/jama.298.17.2038
    1. Dou L., Cerini C., Brunet P., Guillanelli C., Moal V., Grau G., De Smet R., Vanholder R., Sampol J., Berland Y. (2002). P-cresol, a uremic toxin, decreases endothelial cell response to inflammatory cytokines. Kidney Int. 62, 1999–200910.1046/j.1523-1755.2002.t01-1-00651.x
    1. Dulabon L. M., Lowrance W. T., Russo P., Huang W. C. (2010). Trends in renal tumor surgery delivery within the United States. Cancer 116, 2316–2321
    1. Faure V., Cerini C., Paul P., Berland Y., Dignat-George F., Brunet P. (2006). The uremic solute p-cresol decreases leukocyte transendothelial migration in vitro. Int. Immunol. 10, 1453–145910.1093/intimm/dxl077
    1. Fehrman-Ekholm I., Duner F., Brink B., Tydén G., Elinder C. G. (2001). No evidence of accelerated loss of kidney function in living kidney donors: results from a cross sectional follow up. Transplantation 72, 444–44910.1097/00007890-200108150-00015
    1. Foley R. N., Wang C., Collins A. J. (2005). Cardiovascular risk factor profiles and kidney function stage in the US general population: the NHANES 3 study. Mayo Clin. Proc. 80, 1270–127710.4065/80.10.1270
    1. Foyil K. V., Ames C. D., Ferguson, Weld K. J., Figenshau R. S., Venkatesh R., Yan Y., Clayman R. V., Landman J. (2008). Long-term changes in creatinine clearance after laparoscopic renal surgery. J. Am. Coll. Surg. 206, 511–51510.1016/j.jamcollsurg.2007.10.014
    1. Go A. S., Chertow G. M., Fan D., McCulloch C. E., Hsu C. Y. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Eng. J. Med. 351, 1296.10.1056/NEJMoa041031
    1. Goh A., Vathsala A. (2011). Re: native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am. J. Transplant. 11, 86–9210.1111/j.1600-6143.2011.03721.x
    1. Goldfarb D. A., Matin S. F., Braun W. E., Schreiber M. J., Mastroianni B., Papajcik D., Rolin H. A., Flechner S., Goormastic M., Novick A. C. (2001). Renal outcome 25 years after donor nephrectomy. J. Urol. 166, 2043.
    1. Hajj P., Ferlicot S., Massoud W., Awad A., Hammoudi Y., Carpentier B., Durrbach A., Droupy S., Benoit G. (2009). Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure. Urology 74, 631–63410.1016/j.urology.2009.02.078
    1. Henriksen K. J., Meehan S. M., Chang A. (2009). Nonneoplastic kidney diseases in adult tumor nephrectomy and nephroureterectomy specimens: common, harmful, yet underappreciated. Arch. Pathol. Lab. Med. 133, 1012–1025
    1. Hollenback B. K., Tash D. A., Miller D. C., Dunn R. L., Wei J. T. (2006). National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67, 254–25910.1016/j.urology.2005.08.050
    1. Hora M., Hes O., Reischig T., Urge T., Klecka J., Ferda J., Michal M., Eret V. (2008). Tumors in end-stage kidney. Transplant. Proc. 10, 3354–335810.1016/j.transproceed.2008.08.135
    1. Huang W. C., Elkin E. B., Levey A. S., Jang T. L., Russo P. (2009). Partial nephrectomy versus radical nephrectomy in patients with small renal tumors-is there a difference in mortality and cardiovascular outcomes. J. Urol. 181, 55–6210.1016/S0022-5347(09)60167-1
    1. Huang W. C., Levey A. S., Serio A. M., Snyder M., Vickers A. J., Raj G. V., Scardino P. T., Russo P. (2006). Chronic kidney disease after nephrectomy in patients with renal cortical tumors: a retrospective cohort study. Lancet Oncol. 7, 735–74010.1016/S1470-2045(06)70803-8
    1. Ishikawa I., Kovacs G. (1993). High incidence of papillary renal cell tumors in patients on chronic haemodialysis. Histopathology 22, 135–13910.1111/j.1365-2559.1993.tb00091.x
    1. Kaplan C., Pasternack B., Shah H., Gallo G. (1975). Age-related incidence of sclerotic glomeruli in human kidneys. Am. J. Pathol. 80, 227.
    1. Kattan M. W., Reuter V., Motzer R. J., Katz J., Russo P. (2001). A postoperative prognostic nomogram for renal cell. J. Urol. 166, 63–67
    1. Kidney Disease Outcome Quality Initiative (2002). K/DOQI clinical guideline for chronic kidney disease evaluation, classification, stratification. Am. J. Kidney Dis. 39 (Suppl. 2), 51:5246
    1. Lane B. R., Poggio E. D., Herts B. R., Novick A. C., Campbell S. C. (2009). Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care. J. Urol. 182, 436–44410.1016/j.juro.2009.05.112
    1. Lau W. K., Blute M. L., Weaver A. L., Torres V. E., Zincke H. (2000). Matched comparison of radical nephrectomy vs. nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contra lateral kidney. Mayo Clin. Proc. 75, 1236–124210.4065/75.12.1236
    1. Launay-Vacker V., Oudard S., Janus N., Gligorov J., Pourrat X., Rixe O., Morere J. F., Beuzeboc P., Deray G., Renal Insufficiency and Cancer Medications (IRMA) Study Group (2007). Prevalence of renal insufficiency in cancer patients and implications for anti cancer drug management. The renal insufficiency and anticancer medications study (IRMA). Cancer 110, 1376–138410.1002/cncr.22904
    1. Lee J. E., Han S. H., Cho B. C., Park J. T., Yoo T. H., Kim B. S., Park H. C., Kang S. W., Lee H. Y., Han D. S., Ha S. K., Choi K. H. (2009). Cancer in patients on chronic dialysis. J. Korean Med. Sci. 24 (Suppl. 1), S95–S10110.3346/jkms.2009.24.2.296
    1. Liang J. A., Sun L. M., Yeh J. J., Sung F. C., Chang S. N., Kao C. H. (2011). The association between malignancy and end stage renal disease in Taiwan. Jpn. J. Clin. Oncol. 41, 752–75710.1093/jjco/hyr051
    1. Lipworth L., McLaughlin J. K., Tarone R. E., Blot W. J. (2011). Renal cancer paradox: higher incidence but not higher mortality among African-Americans. Eur. J. Cancer Prev. 20, 331–33310.1097/CEJ.0b013e328345f9b3
    1. Ljungberg B., Campbell S. C., Cho H. Y., Jacqmin D., Lee J. E., Weikert S., Kiemeney L. A. (2011). The epidemiology of renal cell carcinoma. Eur. Urol. 60, 615–62110.1016/j.eururo.2011.06.010
    1. Lowrance W. T., Yee D. S., Savage C., Cronin A. M., O’Brien M. F., Donat M., Vickers A., Russo P. (2010). Complications after radical and partial nephrectomy as a function of age. J. Urol. 183, 1725–173010.1016/j.juro.2009.12.021
    1. Mandayam S., Shahinian V. B. (2008). Are chronic dialysis patients at increased risk for cancer? J. Nephrol. 21, 166–174
    1. Matas A. J., Simmons R. L., Kjellstrand C. M., Buselmeier T. J., Naajarian J. S. (1975). Increased incidence of malignancy during chronic renal failure. Lancet 1, 883–88610.1016/S0140-6736(75)91684-0
    1. McKiernan J., Simmons R., Katz J., Russo P. (2002). Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 59, 816–82010.1016/S0090-4295(02)01501-7
    1. McLaughlin J. K., Lipworth L. (2000). Epidemiologic aspects of renal cell cancer. Semin. Oncol. 27, 115–123
    1. Miller D. C., Hollingsworth J. M., Hafez K. S., Daignault S., Hollenbeck B. K. (2006a). Partial nephrectomy for small renal masses. An emerging quality of care concern? J. Urol. 175, 853–85710.1016/S0022-5347(05)00422-2
    1. Miller D. C., Taub D. A., Dunn R. L., Wei J. T., Hollenbeck B. K. (2006b). Laparoscopy for renal cell carcinoma: diffusion versus regionalization? J. Urol. 176, 1102–110610.1016/j.juro.2006.04.101
    1. Mosconi G., Stalterii L., Centofanti F., Capelli I., Carretta E., Persici E., Ubaldi G., Battaglino G., Raimondi C., Scolari M. P., Stefoni S. (2011). Incidence o cancer in kidney transplantation waiting list patients: a single center experience. Transplant. Proc. 43, 1003–100510.1016/j.transproceed.2011.01.121
    1. Neuzillett Y., Mathieu R., Long J. A., Gigante M., Paparel P., Poissonnier L., Baumert H., Escudier B., Lang H., Rioux-Leclercq N., Bigot P., Bernhard J. C., Albiges L., Bastien L., Petit J., Saint F., Bruyere F., Boutin J. M., Brichart N., Karam G., Branchereau J., Ferriere J. M., Wallerand H., Barbet S., Elkentaoui H., Hubert J., Feuillu B., Theveniaud P. E., Villers A., Zini L., Descazeaux A., Roupret M., Barrou B., Fehri K., Lebret T., Tostain J., Terrier J. E., Terrier N., Martin L., Dugardin F., Galliot I., Staerman F., Azemar M. D., Irani J., Tisserand B., Timsit M. O., Sallusto F., Rischmann P., Guy L., Valeri A., Deruelle C., Azzouzi A. R., Chautard D., Mejean A., Salomon L., Rigaud J., Pfister C., Soulié M., Kleinclauss F., Badet L., Patard J. J., Comité de Transplantation de l’Association Française d’Urologie. Comité de Cancérologie de l’Association Française d’Urologie (2011). Renal cell carcinoma (RCC) in patients with end stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur. Urol. 60, 366–37310.1016/j.eururo.2011.02.035
    1. Nouth M. A., Kuroda N., Yamashita M., Hayashida Y., Yano T., Minakuchi J., Taniguchi S., Nomura I., Inui M., Sugimoto M., Kakehi Y. (2009). Renal cell carcinoma in patients with end stage renal disease: relationship between histological type and duration of dialysis. BJU Int. 105, 620–627
    1. Nuttail M., Cathcart van der Meulen, J., Gillatt D., McIntosh G., Emberton M. (2005). A description of radical nephrectomy practice and outcomes in England: 1995-2002. BJU Int. 96, 58–6110.1111/j.1464-410X.2005.05567.x
    1. Ritz E., McClellan W. W. (2004). Overview: increased cardiovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J. Am. Soc. Nephrol. 15, 513–51610.1097/01.ASN.0000115398.92270.30
    1. Russo P. (2000). Renal cell carcinoma: presentation, staging, and surgical treatment. Semin. Oncol. 27, 160–176
    1. Russo P. (2006). “Open radical nephrectomy for localized renal cell carcinoma,” in Genitourinary Oncology, 3rd Edn, ed. Vogelzang N. J. (Philadelphia: Lippincott Williams and Wilkins; ), 725–731
    1. Russo P. (2010). Partial nephrectomy for renal cancer (I). BJU Int. 105, 1206–122010.1111/j.1464-410X.2010.09339.x
    1. Russo P. (2011). The role of surgery in the management of early-stage renal cancer. Hematol. Oncol. Clin. North Am. 25, 737–75210.1016/j.hoc.2011.04.009
    1. Russo P., Jang T., Eggener S., Pettus J., Karellas M., O’Brien F. (2008). Survival rates after resection for localized kidney cancer 1989-2004. Cancer 113, 84–9610.1002/cncr.23520
    1. Sarnak M., Levey A. S., Schoolwerth A. C., Coresh J., Culleton B., Hamm L. L., McCullough P. A., Kasiske B. L., Kelepouris E., Klag M. J., Parfrey P., Pfeffer M., Raij L., Spinosa D. J., Wilson P. W. (2003). Kidney disease as a risk factor for the development of cardiovascular disease: a statement from the American Heart Association Council on Kidney in Cardiovascular Disease. High blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108, 2154–216910.1161/01.CIR.0000095676.90936.80
    1. Segev D. L., Muzaale A. D., Caffo B. S., Mehta S. H., Singer A. L., Taranto S. E., McBride M. A., Montgomery R. A. (2010). Perioperative mortality and long-term survival following live kidney donation. JAMA 503, 959–96610.1001/jama.2010.237
    1. Shlipak M. G., Fried L. F., Cushman M., Manolio T. A., Peterson D., Stehman-Breen C., Bleyer A., Newman A., Siscovick D., Psaty B. (2005). Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 293, 1737–174510.1001/jama.293.14.1737
    1. Stengel B. (2010). Chronic kidney disease and cancer: a troubling connection. J. Nephrol. 23, 253–262
    1. Stenvinkel P. (2010). Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. J. Int. Med. 268, 456–46710.1111/j.1365-2796.2010.02269.x
    1. Stevens L. A., Coresh J., Green T., Levey A. S. (2006). Assessing kidney function – measured and estimated glomerular filtration rate. N. Engl. J. Med. 354, 2473–248310.1056/NEJMra054415
    1. Stevens L. A., Li S., Wang C., Becker B. N., Bomback A. S., Brown W. W., Burrows N. R., Jurkovitz C. T., McFarlane S. I., Norris K. C., Shilpak M., Whaley-Cornell A. T., Chen S. C., Barkis G. L., McCullough P. A. (2010). Prevalence of CKD and co morbid illness in elderly patients in the United State: results from the Kidney Early Evaluation Program (KEEP). Am. J. Kidney Dis. 55 (3 Suppl. 2), S23–S3310.1053/j.ajkd.2009.09.035
    1. Stewart J. H., Vajdoc C. M., van Leeuwen M. T., Amin J., Webster A. C., Chapman J. R., McDonald S. P., Grulich A. E., McCredie M. R. (2009). The pattern of excess cancer in dialysis and transplantation. Nephrol. Dial. Transplant. 10, 3225–323110.1093/ndt/gfp331
    1. Suson K. D., Sausville J. E., Sener A., Phelan M. W. (2011). Native nephrectomy for renal cell carcinoma in transplant recipients. Transplantation 91, 1376–137910.1097/TP.0b013e31821ab97a
    1. Teloken P. E., Thompson R. H., Tickoo S. K., Cronin A., Savage C., Reuter V. E., Russo P. (2009). Prognostic impact of histological subtype in patients with surgically treated localized renal cell carcinoma. J. Urol. 182, 2132–213610.1016/j.juro.2009.07.019
    1. Thompson H. R., Boorjian S. A., Lohse C. M., Leibovich B. C., Kwon E. D., Cheville J. C., Blute M. L. (2008). Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared to partial nephrectomy. J. Urol. 179, 468–47310.1016/S0022-5347(08)60611-4
    1. Thompson H. R., Kaag M., Vickers a., Kundu S., Bernstein M., Lowrance W., Galvin D., Dalbagni G., Touijer K., Russo P. (2009). Contemporary use of partial nephrectomy nephrectomy at a tertiary care center in the United States. J. Urol. 181, 993–99710.1016/j.juro.2008.11.032
    1. Weng P. H., Hung K. Y., Huang H. L., Chen J. H., Sung P. K., Huang K. C. (2011). Cancer specific mortality in chronic kidney disease: longitudinal follow up of a large cohort. Clin. J. Am. Soc. Nephrol. 6, 1121–112810.2215/CJN.09011010
    1. Wong G., Hayen A., Chapman J. R., Webster A. C., Want J. J., Mitchell P., Craig J. C. (2009). Association of CKD and cancer risk in older people. J. Am. Soc. Nephrol. 20, 1341–135010.1681/ASN.2008090998

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する